- Home
- IVA vs ZEPP Comparison
IVA vs ZEPP Comparison
Compare IVA & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- ZEPP
- Stock Information
- Founded
- IVA 2011
- ZEPP 2013
- Country
- IVA France
- ZEPP Netherlands
- Employees
- IVA N/A
- ZEPP N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- ZEPP Computer Manufacturing
- Sector
- IVA Health Care
- ZEPP Technology
- Exchange
- IVA Nasdaq
- ZEPP Nasdaq
- Market Cap
- IVA 769.0M
- ZEPP 696.3M
- IPO Year
- IVA 2020
- ZEPP N/A
- Fundamental
- Price
- IVA $4.21
- ZEPP $24.68
- Analyst Decision
- IVA Strong Buy
- ZEPP
- Analyst Count
- IVA 8
- ZEPP 0
- Target Price
- IVA $16.13
- ZEPP N/A
- AVG Volume (30 Days)
- IVA 492.4K
- ZEPP 371.1K
- Earning Date
- IVA 09-29-2025
- ZEPP 11-04-2025
- Dividend Yield
- IVA N/A
- ZEPP N/A
- EPS Growth
- IVA N/A
- ZEPP N/A
- EPS
- IVA N/A
- ZEPP N/A
- Revenue
- IVA $19,929,536.00
- ZEPP $233,274,000.00
- Revenue This Year
- IVA N/A
- ZEPP $890.13
- Revenue Next Year
- IVA N/A
- ZEPP $25.77
- P/E Ratio
- IVA N/A
- ZEPP N/A
- Revenue Growth
- IVA N/A
- ZEPP 11.64
- 52 Week Low
- IVA $2.11
- ZEPP $2.13
- 52 Week High
- IVA $7.98
- ZEPP $61.85
- Technical
- Relative Strength Index (RSI)
- IVA 44.77
- ZEPP 29.98
- Support Level
- IVA $3.55
- ZEPP $23.80
- Resistance Level
- IVA $4.10
- ZEPP $26.15
- Average True Range (ATR)
- IVA 0.28
- ZEPP 4.08
- MACD
- IVA 0.00
- ZEPP -0.89
- Stochastic Oscillator
- IVA 71.26
- ZEPP 12.08
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.